Affected eyes of AAU patients versus eyes of healthy controls | Affected versus unaffected eye of AAU patients | Affected eyes of bacterial keratitis patients versus eyes of healthy controls | Affected versus unaffected eyes of bacterial keratitis patients | ||||
---|---|---|---|---|---|---|---|
Name | Fold change | Name | Fold change | Name | Protein | Name | Fold change |
SMR3B | 8.4 | SMR3A | 10.7 | S100A9 | 7.6 | ORM2 | 14.1 |
SPARCL1 | 2.7 | CNDP2 | 5.2 | SERPINA3 | 3.4 | CST2 | 5.6 |
PRR27 | 2.4 | KRT4 | 5.0 | CXCL17 | 3.1 | CST5 | 4.7 |
ZG16B | 2.3 | CHI3L2 | 4.4 | APOC3 | 3.1 | CNDP2 | 3.4 |
EEF1A2 | 2.2 | CST5 | 4.1 | LXN | 3.0 | FGB | 2.7 |
MUC5AC | 2.1 | IGHV1-69D | 3.1 | S100P | 2.9 | RARRES1 | 2.7 |
SMR3A | 2.1 | LTF | 2.9 | NDST1 | 2.6 | CST1 | 2.6 |
LPO | 2.0 | KRT13 | 2.6 | A2M | 2.4 | OPRPN | 2.5 |
CALU | 2.0 | OPRPN | 2.4 | CD22 | 2.3 | FGG | 2.4 |
CST2 | 1.9 | KRT19 | 2.3 | SMR3A | 2.1 | FGA | 2.3 |
SCGB2A1 | 1.9 | SERPIND1 | 2.1 | ZG16B | 2.1 | KRT19 | 2.3 |
OPRPN | 1.9 | APOA1 | 2.1 | CST2 | 2.1 | KRT13 | 2.2 |
SERPINA3 | 1.8 | CTSD | 2.0 | IGKV3D-11 | 1.9 | KRT4 | 2.2 |
MYL12B | 1.7 | SCGB2A1 | 1.9 | PLA2G2A | 1.9 | ANXA1 | 2.1 |
ANXA3 | 1.6 | FGG | 1.9 | CALU | 1.8 | KRT7 | 2.1 |